Literature DB >> 15672539

Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy.

Thomas Czech1, Jae-Won Yang, Edina Csaszar, Joachim Kappler, Christoph Baumgartner, Gert Lubec.   

Abstract

Although the syndrome of mesial temporal lobe epilepsy (MTLE) associated with hippocampal sclerosis has been elaborated in recent years, pathogenesis and pathomechanisms are still elusive. Performing protein hunting in hippocampus of patients with MTLE we detected derangement of collapsin response mediated protein-2 (CRMP-2). Hippocampal tissue from controls and MTLEs was taken and two-dimensional gel electrophoresis with subsequent MALDI-MS-characterisation was applied. The proteomic approach identified 13 spots unambiguously assigned to CRMP-2. Three spots at molecular weight 55 kDa showed a significant decrease in MTLE and other 3 spots at 65 kDa showed deranged in MTLE. Immunoblotting revealed two bands at 65 and 55 kDa in the control group whereas the 55 kDa band was extremely low expressed in MTLE. CRMP-2 is required to induce axonal outgrowth and maintaining neuronal polarity in hippocampal neurons and the significant decrease of this protein may represent or underlie impaired neuronal plasticity, neurodegeneration, wiring of the brain in MTLE and may explain abnormal migration. Therefore, the decrease of CRMP-2 may well contribute to the understanding of the still unclear pathomechanisms involved in MTLE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15672539     DOI: 10.1007/s11064-004-7025-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

1.  Differences in protein level between neonatal and adult brain.

Authors:  M Fountoulakis; R Hardmaier; E Schuller; G Lubec
Journal:  Electrophoresis       Date:  2000-02       Impact factor: 3.535

2.  Axon sprouting in a model of temporal lobe epilepsy creates a predominantly excitatory feedback circuit.

Authors:  Paul S Buckmaster; Guo Feng Zhang; Ruth Yamawaki
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

3.  Analysis of the Caenorhabditis elegans axonal guidance and outgrowth gene unc-33.

Authors:  W Li; R K Herman; J E Shaw
Journal:  Genetics       Date:  1992-11       Impact factor: 4.562

4.  Synaptic plasticity in the human dentate gyrus.

Authors:  H Beck; I V Goussakov; A Lie; C Helmstaedter; C E Elger
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

5.  CRMP-2 induces axons in cultured hippocampal neurons.

Authors:  N Inagaki; K Chihara; N Arimura; C Ménager; Y Kawano; N Matsuo; T Nishimura; M Amano; K Kaibuchi
Journal:  Nat Neurosci       Date:  2001-08       Impact factor: 24.884

6.  Chromogranins as markers of altered hippocampal circuitry in temporal lobe epilepsy.

Authors:  S Pirker; T Czech; C Baumgartner; H Maier; K Novak; S Fürtinger; R Fischer-Colbrie; G Sperk
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

7.  Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse.

Authors:  N Arimura; N Inagaki; K Chihara; C Ménager; N Nakamura; M Amano; A Iwamatsu; Y Goshima; K Kaibuchi
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

8.  A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution.

Authors:  N Hamajima; K Matsuda; S Sakata; N Tamaki; M Sasaki; M Nonaka
Journal:  Gene       Date:  1996-11-21       Impact factor: 3.688

Review 9.  Molecular neuropathology of human mesial temporal lobe epilepsy.

Authors:  I Blümcke; H Beck; A A Lie; O D Wiestler
Journal:  Epilepsy Res       Date:  1999-09       Impact factor: 3.045

10.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly.

Authors:  Yuko Fukata; Tomohiko J Itoh; Toshihide Kimura; Céline Ménager; Takashi Nishimura; Takashi Shiromizu; Hiroyasu Watanabe; Naoyuki Inagaki; Akihiro Iwamatsu; Hirokazu Hotani; Kozo Kaibuchi
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

View more
  21 in total

1.  In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation.

Authors:  Yuying Wang; Joel M Brittain; Brian W Jarecki; Ki Duk Park; Sarah M Wilson; Bo Wang; Rachel Hale; Samy O Meroueh; Theodore R Cummins; Rajesh Khanna
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  VOLTAGE-GATED CALCIUM CHANNELS ARE NOT AFFECTED BY THE NOVEL ANTI-EPILEPTIC DRUG LACOSAMIDE.

Authors:  Yuying Wang; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2011-03       Impact factor: 1.757

3.  Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia.

Authors:  Sheng T Hou; Susan X Jiang; Angele Desbois; Deqi Huang; John Kelly; Luc Tessier; Laurie Karchewski; Joachim Kappler
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

Review 4.  Lacosamide: a review of its use as adjunctive therapy in the management of partial-onset seizures.

Authors:  Sheridan M Hoy
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

Review 5.  Key factors in the discovery and development of new antiepileptic drugs.

Authors:  Meir Bialer; H Steve White
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

Review 6.  CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases.

Authors:  T T Quach; J Honnorat; P E Kolattukudy; R Khanna; A M Duchemin
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

Review 7.  Lacosamide.

Authors:  Pamela Doty; G David Rudd; Thomas Stoehr; Dirk Thomas
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 8.  Lacosamide: in partial-onset seizures.

Authors:  Sarah A Cross; Monique P Curran
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 9.  Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide.

Authors:  Sarah M Wilson; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2014-06-20       Impact factor: 5.590

10.  Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety.

Authors:  Christoph Kellinghaus
Journal:  Ther Clin Risk Manag       Date:  2009-09-24       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.